| Literature DB >> 35070562 |
Saurabh Kumar1, Naresh K Midha1, Kamlesh Ahari1, Deepak Kumar1, Maya Gopalakrishnan1, Bharat Kumar1, Gopal K Bohra1, Pawan Garg2, Binit Sureka2, Mahendra Kumar Garg1.
Abstract
Introduction A liver abscess is an important health concern in tropical countries. Effective management of liver abscesses includes appropriate antibiotics and drainage of the abscess cavity. Percutaneous abscess drainage by pigtail catheterization is now gaining popularity. We analyzed the role of pigtail catheter drainage over percutaneous aspiration in the treatment of liver abscesses. Methods and material This was a retrospective analytical study conducted in a tertiary care center in western India. Patients of age ≥ 18 years admitted with the diagnosis of liver abscess were included in this study. To find the effectiveness of different treatment modalities, data were analyzed in three groups: Group A (Conservative treatment), Group B (Percutaneous needle aspiration), and Group C (Pigtail catheter drainage). Results A total of 64 patients with a liver abscess were analyzed. There was male predominance (93.75%). Mean abscess volume in Group C (307.9 ± 212.8 ml) was significantly higher when compared to Group A (130.8 ± 72.9 ml, p = 0.03) and Group B (177.2 ± 129.5; p = 0.024). The duration of hospital stay and residual abscess volume at the time of discharge did not show a statistically significant difference between treatment groups. Pigtail catheterization of abscesses with volume >150 ml shortened the hospital stay, whereas it prolonged the hospital stay in patients with abscess volume <150 ml. Conclusion Percutaneous pigtail catheterization would be an operative decision for the management of liver abscess. We concluded that the use of pigtail catheterization of patients with abscess volume > 150 ml improved the clinical outcome.Entities:
Keywords: amoebic; liver abscess; percutaneous needle aspiration; pigtail catheter drainage; pyogenic
Year: 2021 PMID: 35070562 PMCID: PMC8767523 DOI: 10.7759/cureus.20528
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Demography, etiology, and clinical profile of patients with a liver abscess
| Total patients (n=64) | Parameters | Number (Percentage) |
| Gender | Male | 60 (93.75%) |
| Female | 4 (6.25%) | |
| Risk Factors | Alcoholic | 39 (61%) |
| Smoking | 38 (59.4%) | |
| Diabetic | 6 (9.4%) | |
| Hypertension | 4 (6.25%) | |
| Etiology | Amoebic | 50 (78%) |
| Pyogenic | 4 (6.25%) | |
| Mixed | 3 (4.7%) | |
| Symptoms | Pain abdomen | 54 (84.3%) |
| Fever | 50 (78%) | |
| Anorexia | 40 (62.5%) | |
| Nausea/vomiting | 26 (40.6%) | |
| Weight loss | 26 (40.6%) | |
| Signs | Pallor | 5 (7.8%) |
| Icterus | 5 (7.8%) | |
| Ascites | 8 (12.5%) | |
| Pleural effusion | 19 (29.7%) |
Comparative analysis of data between treatment strategies groups
Hb- Hemoglobin, TLC- Total leukocyte count, ESR- Erythrocyte sedimentation rate, HsCRP- Highly sensitive C-reactive protein, AST- Aspartate aminotransferase, ALT- Alanine aminotransferase
| Variables (Mean±SD) | Total (n=64) | Group A (n=17) | Group B (n=12) | Group C (n=35) | P value |
| Age (Years) | 44±15.3 | 40.1±12.9 | 44.8±20.1 | 45.5±14.4 | 0.51 |
| Duration of Hospital Stay (Days) | 17.8±10.6 | 14.4±13.7 | 16.7±8.4 | 19.8 ± 9.3 | 0.23 |
| Hb (gm%) | 11.7 ± 2.0 | 13.0±2.0 | 11.8±1.6 | 11.0±1.8 | 0.003 |
| TLC | 14133±6197 | 14036±6309 | 11267±6072 | 15275±6006 | 0.14 |
| ESR | 77.6±27.9 | 74.6±26.5 | 68.4±24.7 | 83.1±29.4 | 0.25 |
| HsCRP | 127.1±84.3 | 130.3±107.8 | 126.3±64.9 | 125.8±80.2 | 0.98 |
| AST | 59.1±49.6 | 35.4±18.1 | 56.2±42.9 | 71.4±59.2 | 0.13 |
| ALT | 51.1±41 | 39.1±34.4 | 62.1±46.1 | 52.6±41.5 | 0.31 |
| Total Bilirubin | 1.2±0.9 | 0.9±0.6 | 1.2±0.9 | 1.4±1.1 | 0.21 |
| Abscess Volume on day of admission | 231.5±192.1 | 130.8±72.9 | 177.2±129.5 | 307.9±212.8 | 0.001 |
| Abscess Volume on day of Discharge | 19.9±16 | 16.5±16.6 | 15.8±14.9 | 22.9±15.9 | 0.26 |
| Duration of Metronidazole | 23.1±8 | 20.4±6.3 | 23.4±7.5 | 24.3±8.7 | 0.29 |
Figure 1Association between duration of hospitalization and treatment strategies according to liver abscess volume
Distribution of amoebic etiology and right lobe involvement in different treatment strategies
| Variables | Group A (n=17) | Group B (n=12) | Group C (n=35) | P-value |
| Amoebic Etiology | 13 (76%) | 10 (83%) | 27 (77%) | 0.19 |
| Right Lobe Involvement | 12 (70%) | 10 (83%) | 29 (82%) | 0.65 |